Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 26, 2013

JAZZ PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL, INC.

Track this case

Case Number:

2:13-cv-07884

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Esther Salas

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 25, 2014

    Drug Challenged Under AIA Biz Method Review For 1st Time

    Amneal Pharmaceuticals LLC and others asked the Patent Trial and Appeal Board on Tuesday to invalidate a patent for distribution of Jazz Pharmaceuticals Inc.'s narcolepsy drug Xyrem as an abstract idea, the first time the America Invents Act's business method review program has been used in a drug case.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login